References
1. Abdullaev R., Komissarova O. Laboratory indicators of coronavirus infection COVID-19. Vrach [Physician]. 2020; 31 (5): 3–6. DOI: https://doi.org/10.29296/25877305-2020-05-01 (in Russian)
2. Glybochko P., Fomin V., Moiseev S., et al. Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia. Klinicheskaya farmakologia i terapia [Clinical Pharmacology and Therapy]. 2020; 29 (3): 25–36. DOI: https://doi.org/10.32756/0869-54902020-3-25-36 (in Russian)
3. Guan W.J., Ni Z.Y., Hu Y., et al.; China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708–20. DOI: https://doi.org/10.1056/NEJMoa2002032
4. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061–9. DOI: https://doi.org/10.1001/jama.2020.1585
5. Bhatraju P.K., Ghassemieh B.J., Nichols M., et al. COVID-19 in critically ill patients in the Seattle Region – Case Series. N Engl J Med. 2020; 382 (21): 2012–22. DOI: https://doi.org/10.1056/NEJMoa2004500
6. Martínez-Colón G.J., Ratnasiri K., Chen H., et al. SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19. bioRxiv. Preprint. 2021. DOI: https://doi.org/10.1101/2021.10.24.465626
7. Lippi G., Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020; 505: 190–1. DOI: https://doi.org/10.1016/j.cca.2020.03.004
8. Herold T., Jurinovic V., Arnreich C., et al. Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020; 146 (1): 128–36.e4. DOI: https://doi.org/10.1016/j.jaci.2020.05.008
9. Chen H., Guo J., Wang C., et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395 (10 226): 809–15. DOI: https://doi.org/10.1016/S0140-6736(20)30360-3
10. Zippi M., Fiorino S., Occhigrossi G., Hong W. Hypertransaminasemia in the course of infection with SARS-CoV-2: incidence and pathogenetic hypothesis. World J Clin Cases. 2020; 8 (8): 1385–90. DOI: https://doi.org/10.12998/wjcc.v8.i8.1385
11. Liu Y., Yang Y., Zhang C., et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020; 63 (3): 364–74. DOI: https://doi.org/10.1007/s11427-020-1643-8
12. Lippi G., Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020; 42 (2): 116–7. DOI: https://doi.org/10.1016/j.htct.2020.03.001
13. Lippi G., Favaloro E.J. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020; 120 (5): 876–8. DOI: https://doi.org/10.1055/s-0040-1709650
14. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18 (4): 844–7. DOI: https://doi.org/10.1111/jth.14768
15. Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q., et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75 (7): 1730–41. DOI: https://doi.org/10.1111/all.14238
16. Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020; 506: 145–8. DOI: https://doi.org/10.1016/j.cca.2020.03.022